HUE037889T2 - Ulipristal acetát melltumorok megelõzésére és kezelésére - Google Patents
Ulipristal acetát melltumorok megelõzésére és kezeléséreInfo
- Publication number
- HUE037889T2 HUE037889T2 HUE13724304A HUE13724304A HUE037889T2 HU E037889 T2 HUE037889 T2 HU E037889T2 HU E13724304 A HUE13724304 A HU E13724304A HU E13724304 A HUE13724304 A HU E13724304A HU E037889 T2 HUE037889 T2 HU E037889T2
- Authority
- HU
- Hungary
- Prior art keywords
- prevention
- treatment
- breast tumors
- ulipristal acetate
- ulipristal
- Prior art date
Links
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 title 1
- 229960000499 ulipristal acetate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305586 | 2012-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE037889T2 true HUE037889T2 (hu) | 2018-09-28 |
Family
ID=48471021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13724304A HUE037889T2 (hu) | 2012-05-25 | 2013-05-24 | Ulipristal acetát melltumorok megelõzésére és kezelésére |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150133418A1 (enExample) |
| EP (1) | EP2854817B1 (enExample) |
| JP (1) | JP6322623B2 (enExample) |
| KR (1) | KR20150039130A (enExample) |
| AU (1) | AU2013265163B2 (enExample) |
| CA (1) | CA2874530A1 (enExample) |
| ES (1) | ES2672727T3 (enExample) |
| HU (1) | HUE037889T2 (enExample) |
| IL (1) | IL235847B (enExample) |
| WO (1) | WO2013175009A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017216637A2 (en) | 2017-08-04 | 2017-12-21 | Alvogen Malta Operations (Row) Ltd | Tablet form including ulipristal acetate and the methods for its preparation |
| KR102864826B1 (ko) | 2023-02-07 | 2025-09-29 | 재단법인 아산사회복지재단 | 항암제에 대한 치료 반응성을 예측하기 위한 조성물 및 이의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954490A (en) | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| US5747282A (en) | 1994-08-12 | 1998-05-05 | Myraid Genetics, Inc. | 17Q-linked breast and ovarian cancer susceptibility gene |
| US5929262A (en) | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
| US5965377A (en) | 1997-03-24 | 1999-10-12 | Baystate Medical Center | Method for determining the presence of mutated BRCA protein |
| US6514713B1 (en) | 2001-07-03 | 2003-02-04 | Hybritech Incorporated | Methods of detecting BRCA1 mutations |
| ES2212912B1 (es) | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
| US20060111577A1 (en) | 2003-02-28 | 2006-05-25 | Kim Hyun K | Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| WO2007103510A2 (en) * | 2006-03-08 | 2007-09-13 | Danco Laboratories Llc | Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders |
| US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
-
2013
- 2013-05-24 HU HUE13724304A patent/HUE037889T2/hu unknown
- 2013-05-24 WO PCT/EP2013/060801 patent/WO2013175009A1/en not_active Ceased
- 2013-05-24 KR KR1020147036629A patent/KR20150039130A/ko not_active Abandoned
- 2013-05-24 US US14/403,304 patent/US20150133418A1/en not_active Abandoned
- 2013-05-24 CA CA2874530A patent/CA2874530A1/en not_active Abandoned
- 2013-05-24 AU AU2013265163A patent/AU2013265163B2/en not_active Ceased
- 2013-05-24 ES ES13724304.4T patent/ES2672727T3/es active Active
- 2013-05-24 EP EP13724304.4A patent/EP2854817B1/en not_active Not-in-force
- 2013-05-24 JP JP2015513217A patent/JP6322623B2/ja not_active Expired - Fee Related
-
2014
- 2014-11-23 IL IL235847A patent/IL235847B/en not_active IP Right Cessation
-
2016
- 2016-07-29 US US15/223,066 patent/US9814732B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL235847B (en) | 2020-03-31 |
| IL235847A0 (en) | 2015-01-29 |
| AU2013265163A1 (en) | 2014-12-18 |
| JP6322623B2 (ja) | 2018-05-09 |
| ES2672727T3 (es) | 2018-06-15 |
| WO2013175009A1 (en) | 2013-11-28 |
| EP2854817A1 (en) | 2015-04-08 |
| US9814732B2 (en) | 2017-11-14 |
| EP2854817B1 (en) | 2018-03-21 |
| KR20150039130A (ko) | 2015-04-09 |
| US20170014426A1 (en) | 2017-01-19 |
| CA2874530A1 (en) | 2013-11-28 |
| JP2015520763A (ja) | 2015-07-23 |
| AU2013265163B2 (en) | 2017-08-10 |
| US20150133418A1 (en) | 2015-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL312551B2 (en) | GRPR antagonists for detection, diagnosis and treatment of GRPR-positive cancer | |
| IL234678A0 (en) | Diagnostic methods and preparations for cancer treatment | |
| IL237558A0 (en) | Methods for treating locally advanced breast cancer | |
| IL238254A0 (en) | Cancer treatment methods | |
| HUE046788T2 (hu) | Gyógyászati készítmény rák kezelésére és/vagy megelõzésére | |
| HUE044611T2 (hu) | Gyógyászati készítmény rák kezelésére | |
| HUE045461T2 (hu) | Gyógyászati készítmény rák kezelésére | |
| PH12014500248A1 (en) | Treatment of breast cancer | |
| IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
| IL261659A (en) | Brain cancer treatment | |
| EP2903644A4 (en) | TREATMENT OF CANCER | |
| IL239374A0 (en) | Preparations and methods for treating brain tumors | |
| GB201217892D0 (en) | Treatment of cancer | |
| SI2892925T1 (sl) | Kombinacijsko zdravljenje raka | |
| GB201412831D0 (en) | Detection and treatment of breast cancer | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| IL235847B (en) | Olipristal acetate for the prevention and treatment of breast tumors | |
| GB2519004B (en) | Quinone compounds and their uses for the treatment of cancer | |
| GB201217890D0 (en) | Treatment of cancer | |
| IL237229A0 (en) | Methods of treating cancer using lipoplatin | |
| GB201208296D0 (en) | Treatment of cancer | |
| GB201222950D0 (en) | Combination treatment of cancer | |
| GB201222949D0 (en) | Combination Treatment of Cancer | |
| GB201208048D0 (en) | Treatment of digestive disorder | |
| GB201301685D0 (en) | Diagnosis and treatment of cancer |